Anti-tumour necrosis factor α monoclonal antibody therapy for recalcitrant cerebral vasculitis in a patient with Behçet's syndrome

Samankaltaisia teoksia

• Anti-tumour necrosis factor monoclonal antibody treatment for ocular Behçet's disease
  Tekijä: Triolo, G, et al.
  Julkaistu: (2002)
• Tumour necrosis factor α blockade and the risk of vasculitis
  Tekijä: De Bandt, M, et al.
  Julkaistu: (2006)
• Vγ9/Vδ2 T lymphocytes in Italian patients with Behçet's disease: evidence for expansion, and tumour necrosis factor receptor II and interleukin-12 receptor β(1 )expression in active disease
  Tekijä: Triolo, Giovanni, et al.
  Julkaistu: (2003)
• Humoral and cell mediated immune response to cow's milk proteins in Behçet's disease
  Tekijä: Triolo, G, et al.
  Julkaistu: (2002)
• Remission of Behçet's syndrome with tumour necrosis factor α blocking therapy
  Tekijä: Goossens, P, et al.
  Julkaistu: (2001)